Position in FLGT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$895,313
-$89,706 QoQ
Shares Held
56,309
+50.2% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FLGT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $9,521,154 across 13 Diagnostics & Research names. FLGT ranks #5 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SHC |
Sotera Health Co
|
108,608 | $1,557,438 | |
| 2 | GH |
Guardant Health, Inc.
|
16,636 | $1,536,667 | |
| 3 | NTRA |
Natera, Inc.
|
5,676 | $1,135,143 | |
| 4 | TWST |
Twist Bioscience Corp
|
21,687 | $1,030,566 | |
| 5 | FLGT |
Fulgent Genetics, Inc.
This page
|
56,309 | $895,313 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
5,138 | $876,234 | |
| 7 | DHR |
Danaher Corp /De/
|
2,693 | $510,592 | |
| 8 | TMO |
Thermo Fisher Scientific Inc.
|
836 | $410,919 |
All Filings in FLGT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $895,313 | 56,309 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $985,019 | 37,496 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,563,761 | 69,193 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,370,944 | 68,961 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,416,405 | 83,811 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $285,232 | 15,443 | Shares | Other | 2025-02-14 | |
| 2020-03-31 | $10,135 | 942 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||